CAS 1007581-62-5

Cancer-Targeting Compound 1

CAS: 1007581-62-5

Cancer-Targeting Compound 1

Reinheit: ≥98%

Molekulargewicht: 299.35g/mol

Ref: 54-BUP08829

Cancer-targeting 1

CAS: 1007581-62-5

Cancer-targeting 1 is an antibody that inhibits the binding of peptide ligands to cell surface receptors by competing with them for binding. It has been shown to inhibit receptor activation and ion channel gating in vitro. This antibody is also a research tool for studying protein interactions, receptor activation, and signal transduction. Cancer-targeting 1 has a high purity and can be used as a reagent for use in life science applications such as Cell Biology, Pharmacology, or Ligand Activation.

Formel: C₁₅H₁₃N₃O₂S

Reinheit: Min. 95%

Molekulargewicht: 299.3 g/mol

Ref: 3D-HQB58162

Cancer-Targeting Compound 1

CAS: 1007581-62-5

Cancer-Targeting Compound 1 can be used in the study of hormone-related cancers, including the treatment or prevention of fibroids, uterine leiomyomas,

Formel: C₁₅H₁₃N₃O₂S

Reinheit: 99.83%

Farbe und Form: Solid

Molekulargewicht: 299.35

Ref: TM-T13572